Integrated Diagnostics Holdings plc
IDGXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $6 | $4 | $4 | $5 |
| % Growth | 38.7% | 14.4% | -31% | – |
| Cost of Goods Sold | $4 | $3 | $2 | $2 |
| Gross Profit | $2 | $2 | $1 | $3 |
| % Margin | 38.1% | 37% | 40.6% | 53.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | $1 | $1 | $1 | $2 |
| % Margin | 21.2% | 17.9% | 23.1% | 43.3% |
| Other Income/Exp. Net | $0 | -$0 | $0 | -$0 |
| Pre-Tax Income | $1 | $1 | $1 | $2 |
| Tax Expense | $0 | $0 | $0 | $1 |
| Net Income | $1 | $1 | $1 | $1 |
| % Margin | 18.8% | 12.4% | 15% | 27% |
| EPS | 1.82 | 0.85 | 0.9 | 2.35 |
| % Growth | 114.1% | -5.6% | -61.7% | – |
| EPS Diluted | 1.82 | 0.85 | 0.9 | 2.35 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $2 | $1 | $1 | $3 |
| % Margin | 36.6% | 31.1% | 35.9% | 49.2% |